Integrated Biopharma Buy Hold or Sell Recommendation
INBPDelisted Stock | USD 0.33 0.00 0.00% |
Given the investment horizon of 90 days and your complete indifference towards market risk, our recommendation regarding Integrated Biopharma is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Integrated Biopharma given historical horizon and risk tolerance towards Integrated Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Integrated Biopharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note, we conduct extensive research on individual companies such as Integrated and provide practical buy, sell, or hold advice based on investors' constraints. Integrated Biopharma. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Integrated |
Execute Integrated Biopharma Buy or Sell Advice
The Integrated recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Integrated Biopharma. Macroaxis does not own or have any residual interests in Integrated Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Integrated Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Not Rated
Integrated Biopharma Trading Alerts and Improvement Suggestions
Integrated Biopharma is not yet fully synchronised with the market data | |
Integrated Biopharma has some characteristics of a very speculative penny stock | |
Integrated Biopharma has a very high chance of going through financial distress in the upcoming years | |
About 69.0% of the company shares are held by company insiders |
Integrated Biopharma Returns Distribution Density
The distribution of Integrated Biopharma's historical returns is an attempt to chart the uncertainty of Integrated Biopharma's future price movements. The chart of the probability distribution of Integrated Biopharma daily returns describes the distribution of returns around its average expected value. We use Integrated Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Integrated Biopharma returns is essential to provide solid investment advice for Integrated Biopharma.
Mean Return | -0.13 | Value At Risk | -5.56 | Potential Upside | 3.13 | Standard Deviation | 4.05 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Integrated Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Integrated Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Integrated . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
Accumulation Distribution | 0.0303 | |||
Rate Of Daily Change | 1.0 | |||
Day Median Price | 0.33 | |||
Day Typical Price | 0.33 | |||
Market Facilitation Index | 0.01 | |||
Price Action Indicator | 0.005 | |||
Relative Strength Index | 2.24 |
About Integrated Biopharma Buy or Sell Advice
When is the right time to buy or sell Integrated Biopharma? Buying financial instruments such as Integrated OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Integrated Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Market Neutral Funds Thematic Idea Now
Market Neutral Funds
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Integrated Biopharma information on this page should be used as a complementary analysis to other Integrated Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Integrated OTC Stock
If you are still planning to invest in Integrated Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Integrated Biopharma's history and understand the potential risks before investing.
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |